000 01553 a2200385 4500
005 20250517211119.0
264 0 _c20190930
008 201909s 0 0 eng d
022 _a1556-1380
024 7 _a10.1016/j.jtho.2018.03.026
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbravanel, Daniel L
245 0 0 _aAn Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.
_h[electronic resource]
260 _bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
_c08 2018
300 _ae131-e133 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdenocarcinoma of Lung
_xdrug therapy
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aMutation
650 0 4 _aOximes
_xtherapeutic use
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aPyridones
_xtherapeutic use
650 0 4 _aPyrimidinones
_xtherapeutic use
700 1 _aNishino, Mizuki
700 1 _aSholl, Lynette M
700 1 _aAmbrogio, Chiara
700 1 _aAwad, Mark M
773 0 _tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
_gvol. 13
_gno. 8
_gp. e131-e133
856 4 0 _uhttps://doi.org/10.1016/j.jtho.2018.03.026
_zAvailable from publisher's website
999 _c28263521
_d28263521